Rob Holgate

Vice President of Research & Innovation

Rob Holgate PhD studied at Kings College, London where he obtained a First Class (Hons) degree in Biochemistry. After obtaining his PhD in Molecular Medicine at The Institute of Child Health, part of University College, London, he moved to The University of York as a post-doctoral researcher. Rob formally worked at Cambridge Antibody Technology where he was a Senior Scientist within Antibody Engineering then Team Leader of the High Throughput Expression team. Rob joined Antitope (now Abzena) in 2008 as a Research Manager and now leads Abzena’s Protein Engineering and Antibody Discovery groups overseeing Abzena’s discovery, antibody humanization, protein deimmunization and bespoke engineering projects.

Contact Our Expert

What is your biologic drug development challenge? Ask our expert today. We are ready to help.